These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 19765581)

  • 1. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
    Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
    Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
    Yoshida T; Okuno A; Izumi M; Takahashi K; Hagisawa Y; Ohsumi J; Fujiwara T
    Eur J Pharmacol; 2008 Dec; 601(1-3):192-7. PubMed ID: 19014931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
    Yoshida T; Okuno A; Takahashi K; Ogawa J; Hagisawa Y; Kanda S; Fujiwara T
    J Pharmacol Sci; 2011; 115(3):329-35. PubMed ID: 21350313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
    van Poelje PD; Potter SC; Chandramouli VC; Landau BR; Dang Q; Erion MD
    Diabetes; 2006 Jun; 55(6):1747-54. PubMed ID: 16731838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
    van Poelje PD; Potter SC; Erion MD
    Handb Exp Pharmacol; 2011; (203):279-301. PubMed ID: 21484576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute effect of metformin on glucose production in the conscious dog is primarily attributable to inhibition of glycogenolysis.
    Chu CA; Wiernsperger N; Muscato N; Knauf M; Neal DW; Cherrington AD
    Metabolism; 2000 Dec; 49(12):1619-26. PubMed ID: 11145127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes.
    Mueller WM; Stanhope KL; Gregoire F; Evans JL; Havel PJ
    Obes Res; 2000 Oct; 8(7):530-9. PubMed ID: 11068959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.
    Erion MD; van Poelje PD; Dang Q; Kasibhatla SR; Potter SC; Reddy MR; Reddy KR; Jiang T; Lipscomb WN
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7970-5. PubMed ID: 15911772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.
    Doi M; Yamaoka I; Nakayama M; Sugahara K; Yoshizawa F
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1683-93. PubMed ID: 17299083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of (13)C-filtered (1)H NMR to evaluate drug action on gluconeogenesis and glycogenolysis simultaneously in isolated rat hepatocytes.
    Hansen SH; McCormack JG
    NMR Biomed; 2002 Aug; 15(5):313-9. PubMed ID: 12203222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.
    Owen MR; Doran E; Halestrap AP
    Biochem J; 2000 Jun; 348 Pt 3(Pt 3):607-14. PubMed ID: 10839993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.
    Matsuura B; Kanno S; Minami H; Tsubouchi E; Iwai M; Matsui H; Horiike N; Onji M
    J Gastroenterol; 2004; 39(4):339-45. PubMed ID: 15168245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic actions of arachidonic acid and zinc in genetically diabetic Goto-Kakizaki rats.
    Song MK; Hwang IK; Rosenthal MJ; Harris DM; Yamaguchi DT; Yip I; Go VL
    Metabolism; 2003 Jan; 52(1):7-12. PubMed ID: 12524655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress.
    Rösen P; Wiernsperger NF
    Diabetes Metab Res Rev; 2006; 22(4):323-30. PubMed ID: 16444763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased alanine uptake and lipid synthesis from alanine in isolated hepatocytes of Wistar-Kyoto fatty rats: an inhibitory effect of biguanides.
    Mori K; Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Komori T; Nakashima E; Naruse K; Takeuchi N; Hotta N
    Can J Physiol Pharmacol; 1997 Mar; 75(3):179-84. PubMed ID: 9164699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sources of endogenous glucose production in the Goto-Kakizaki diabetic rat.
    Sena CM; Barosa C; Nunes E; Seiça R; Jones JG
    Diabetes Metab; 2007 Sep; 33(4):296-302. PubMed ID: 17553720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of a novel method for evaluating gluconeogenesis using hepatic cell lines, H4IIE and HepG2.
    Okamoto T; Kanemoto N; Ban T; Sudo T; Nagano K; Niki I
    Arch Biochem Biophys; 2009 Nov; 491(1-2):46-52. PubMed ID: 19799852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats.
    Louro TM; Matafome PN; Nunes EC; da Cunha FX; Seiça RM
    Eur J Pharmacol; 2011 Feb; 653(1-3):89-94. PubMed ID: 21167150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.